Frank Maddux, global chief medical officer for Fresenius Medical Care, and we've been discussing the potential impact of GLP-1 receptor agonists and SGLT-2 inhibitors on chronic kidney disease care
In the United States, list prices for GLP-1 drugs have historically ranged between $1,000 and $1,300 per month
Recent evidence shows that individuals with specific genetic variants in the GLP-1 receptor pathway (such as GLP1R rs6923761) may have different metabolic responses to treatment, suggesting that personalized assessment before ordering can optimize selection
J Nutr Sci Vitaminol 57(3):246250 Trexler ET, Persky AM, Ryan ED, Schwartz TA, Stoner L, Smith-Ryan AE (2019a) Acute effects of citrulline supplementation on high-intensity strength and power performance: a systematic review and meta-analysis
PMC 4159612